Motorola enhances video security solutions portfolio with new buyout
Category: #business  By Mateen Dalal  Date: 2019-07-16
  • share
  • Twitter
  • Facebook
  • LinkedIn

Motorola enhances video security solutions portfolio with new buyout

The acquisition aims at adding new features and enhancing Motorola’s existing video security solutions portfolio.


Motorola – the American multinational telecommunications giant has reportedly acquired Texas based mobile video solutions company, WatchGuard.

For the record, WatchGuard designs and manufactures in- car video systems, evidence management systems and software and body worn cameras. Their products enable law enforcement users to capture, manage, record and share high quality evidences.

John Kedzierski, Senior Vice – President of Video Security Solutions at Motorola, was reportedly quoted stating that an integrated and secure mobile video solution provides safety and enhances efficiency for law enforcement users. He further claimed that WatchGuard is a leading video solutions company with enhanced features for instance, capturing incidents from several vantage points to technology that allows the users to recover and upload videos from events that may have taken place hours or days ago, he further added.

Reportedly, the acquisition enables the expansion of Motorola’s mission critical ecosystem adding to the company’s video security solutions platform which includes advanced analytics and fixed cameras by Avigilon and license plate recognition (LPR) software and cameras from Vigilant Solutions. 

For the record, WatchGuard marks the third acquisition by the company in the year 2019. So far, the company has made 40 acquisitions over its lifetime with the latest being VaaS International Holdings, a license plate recognition software for $ 445 million in cash and stock.

According to Robert Vanman, Founder, CEO and Chairman, Watchguard, the acquisition will allow the company to offer leading mobile video solutions to existing customers along with leveraging Motorola’s presence globally and add to its growing video security portfolio, he further claimed.

According to trusted sources, terms of the deal have not been disclosed so far.

About Motorola

Founded in 1928 in Chicago by Paul and Joseph Galvin, the company serves over 1 lakh public safety and commercial clients in more than 100 countries. Citing a report by the company, the annual sales recorded in the year 2018 accounted to $7.3 billion.

Source Credits: https://www.channelnews.com.au/motorola-acquires-watchguard/

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Cryptocurrency platform Binance acquires dApp startup DappReview
Cryptocurrency platform Binance acquires dApp startup DappReview
By Mateen Dalal

Binance, a renowned cryptocurrency exchange platform where more than 100 cryptocurrencies are traded, reportedly announced the acquisition of DappReview, an evaluation platform offering advertising and data-driven research services to blockchain-base...

Amneal gains FDA nod for launch of Revatio® & Amicar® tablets
Amneal gains FDA nod for launch of Revatio® & Amicar® tablets
By Mateen Dalal

Amneal Pharmaceuticals, Inc. has made some consistent ripples in the generics and specialty pharmaceutical industry. Recently, the company made headlines when it revealed attaining final approval from the U.S. FDA on its ANDA (Abbreviated New Drug Ap...

Prescient expands PTX-200 trial after it eradicates cancer completely
Prescient expands PTX-200 trial after it eradicates cancer completely
By Mateen Dalal

Prescient Therapeutics, a renowned small molecule drug development firm aimed at developing new cancer therapies, reportedly announced that it is extending its Phase 1b trial in patients with AML (acute myeloid leukemia) after the disease was complet...